Drug recall · April 17, 2019
Losartan Potassium 100 mg Tablets # 30 Losartan potassium tablets USP recall
Why: CGMP Deviations:Traces amounts of N-Nitroso N-Methyl 4- amino butyric acid (NMBA) impurity found in Active Pharmaceutical Ingredient (API).
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan Potassium 100 mg Tablets # 30 Losartan potassium tablets USP, 100 mg are white to off white, film coated, tear drop shaped tablets, debossed with "H" on one side and "145" on the other side.
- Lots / codes
Pharma Pac NDC: 76519-1033-03, Pharma Pac Lot # LTO00EW, Exp. 11/19, MFG NDC 31722-0702-30, MFG Lot # LOP17087, Exp. 11/2019.
- Quantity
- 300 tablets
- Company
- H J Harkins Company Inc dba Pharma Pac, Grover Beach, CA
- Distribution
- Product was distributed to a physician's office in California.
- Initiated
- March 4, 2019 · Voluntary: Firm initiated
- Classified
- April 7, 2019
- Reported
- April 17, 2019
- Ended
- May 24, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.